Develops rationally designed AAV gene therapies for devastating rare and prevalent diseases, focusing on heart and nervous system.[1][2]
Get notified the moment Affinia Therapeutics files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.